At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 13 enrolled
Drug / intervention
Placebo +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pharmacological Therapy for Calcium Phosphate Urolithiasis
University of Texas Southwestern Medical Center·interventional·Posted Dec 21, 2012·Updated Apr 4, 2024
In Brief
A Phase 2 clinical trial evaluating Placebo, Citric Acid, and 1 other intervention for Calcium Phosphate Kidney Stones. Completed, enrolled 13 participants across 1 site.
Detailed Summary
The investigators will examine in two studies whether citric acid or potassium citrate can reduce calcium phosphate saturation in urine of Calcium Phosphate stone formers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCalcium Phosphate Kidney Stones
CountriesUnited States
Timeline
Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2012
First PostedDec 2012
Primary CompletionFeb 2023
TodayJul 2026
First PostedDec 21, 2012
Enrollment StartJul 1, 2012
Primary CompletionFeb 16, 2023
TodayJul 2, 2026
Enrollment to primary: 10.6 yearsPosted 13.5 years ago
Interventions
Placebodietary
3 tablets twice daily of matching placebo during the placebo phase.
Citric Aciddietary
3, 10 mEq tablets of H3Cit twice daily during the H3Cit phase (60 mEq H3Cit per day)
Potassium Citratedietary
2, 10 mEq K3Cit tablets and 1 placebo tablet twice daily during the K3Cit phase (40 mEq K3Cit per day)